| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |